Literature DB >> 2795628

Castigating QALYs.

J Rawles1.   

Abstract

The ethical problem of how to apportion limited resources amongst the needy has been forced on us by arbitrary limitation of health expenditure. Its solution would not be required if health expenditure were higher. Distribution of resources according to best value for money, assessed as Quality Adjusted Life Years (QALYs) per unit cost, has been suggested as a possible solution, but leads to absurd anomalies. In the calculation of QALYs the implied value of life is no more than the absence of suffering. The use of QALYs for the comparison of treatments that are symptomatic or life-saving therefore leads to serious undervaluation of life and treatments that prolong it. Moreover, distribution of resources by best value for money, however assessed, is inequitable since for a given degree of suffering those whose illnesses happen to be cheaper to treat will be treated in preference to those whose treatments are more expensive.

Entities:  

Keywords:  Health Care and Public Health; National Health Service

Mesh:

Year:  1989        PMID: 2795628      PMCID: PMC1375805          DOI: 10.1136/jme.15.3.143

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  5 in total

1.  Economics of coronary artery bypass grafting.

Authors:  A Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

2.  QALYfying the value of life.

Authors:  J Harris
Journal:  J Med Ethics       Date:  1987-09       Impact factor: 2.903

3.  Qualms about QALYs.

Authors:  A Smith
Journal:  Lancet       Date:  1987-05-16       Impact factor: 79.321

4.  Logic in medicine: an economic perspective.

Authors:  A Maynard
Journal:  Br Med J (Clin Res Ed)       Date:  1987-12-12

5.  A scale of valuations of states of illness: is there a social consensus?

Authors:  R Rosser; P Kind
Journal:  Int J Epidemiol       Date:  1978-12       Impact factor: 7.196

  5 in total
  14 in total

1.  Economic evaluation of pharmaceuticals: a critical appraisal of seven studies on cholesterol-lowering agents.

Authors:  P Gazzaniga; L Garattini
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981

2.  A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.

Authors:  L Garattini; R Grilli; D Scopelliti; L Mantovani
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

3.  Assessing the benefits of health care: how far should we go?

Authors:  M Ryan; P Shackley
Journal:  Qual Health Care       Date:  1995-09

4.  Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?

Authors:  Livio Garattini; Anna Padula
Journal:  J R Soc Med       Date:  2017-01-24       Impact factor: 5.344

5.  The QALY argument: a physician's and a philosopher's view.

Authors:  J Rawles; K Rawles
Journal:  J Med Ethics       Date:  1990-06       Impact factor: 2.903

6.  Rationing is not inevitable.

Authors:  W Podmore
Journal:  BMJ       Date:  1995-07-08

7.  Rationing health care resources. Is the quality-adjusted life-year a helpful guide?

Authors:  J M Warren
Journal:  Can Fam Physician       Date:  1994-01       Impact factor: 3.275

Review 8.  Good quality quality? Some methodological issues.

Authors:  C E Selai; R M Rosser
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 5.344

Review 9.  A review of quality-of-life evaluations in patients with congestive heart failure.

Authors:  C Berry; J McMurray
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

10.  The principle of QALY maximisation as the basis for allocating health care resources.

Authors:  J Cubbon
Journal:  J Med Ethics       Date:  1991-12       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.